Skip to main content
Equibles

RDY · Dr Reddys Laboratories Ltd · Earnings Call Transcripts & Audio

Track RDY — free

Use RDY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RDY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.90 +0.19 (+1.62%) At close · Sep 11
Rebalance outlook locked
Market Cap
$9.91B
Shares
832.99M

Dr Reddys Laboratories Ltd Earnings Call Transcripts

Quarterly earnings calls for Dr Reddys Laboratories Ltd (RDY), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q2
2025-09-30
Dr Reddys Laboratories Ltd (RDY) Q2 2026 Earnings Call Transcript
Positive tone Biosimilars pipeline (rituximab, abatacept, tocilizumab) Margins and cost optimization GLP-1 / peptides opportunity
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-06-30
Dr Reddys Laboratories Ltd (RDY) Q1 2026 Earnings Call Transcript
Positive tone Semaglutide opportunity R&D and innovation investment Biosimilars and complex pipeline
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-03-31
Dr Reddys Laboratories Ltd (RDY) Q4 2025 Earnings Call Transcript
Confident tone Gross margin pressure R&D and pipeline investment Revenue and EBITDA growth
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2024-12-31
Dr Reddys Laboratories Ltd (RDY) Q3 2025 Earnings Call Transcript
Positive tone Semaglutide and GLP-1 opportunity Biosimilars pipeline North America generics
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-09-30
Dr Reddys Laboratories Ltd (RDY) Q2 2025 Earnings Call Transcript
Confident tone R&D and pipeline Russia and CIS business Margins and cost structure
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-06-30
Dr Reddys Laboratories Ltd (RDY) Q1 2025 Earnings Call Transcript
Confident tone India branded generics market SG&A cost pressure and margins Consumer healthcare business build-out
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-03-31
Dr Reddys Laboratories Ltd (RDY) Q4 2024 Earnings Call Transcript
Positive tone R&D Investment Biosimilars Pipeline PSAI Segment
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2023-09-30
Dr Reddys Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-06-30
Dr Reddys Laboratories Ltd (RDY) Q1 2024 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-03-31
Dr Reddys Laboratories Ltd (RDY) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2022-12-31
Dr Reddys Laboratories Ltd (RDY) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-09-30
Dr Reddys Laboratories Ltd (RDY) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-06-30
Dr Reddys Laboratories Ltd (RDY) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-03-31
Dr Reddys Laboratories Ltd (RDY) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2021-12-31
Dr Reddys Laboratories Ltd (RDY) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-03-31
Dr Reddys Laboratories Ltd (RDY) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2020-12-31
Dr Reddys Laboratories Ltd (RDY) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-06-30
Dr Reddys Laboratories Ltd (RDY) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2019-12-31
Dr Reddys Laboratories Ltd (RDY) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2019-09-30
Dr Reddys Laboratories Ltd (RDY) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–20 of 20 earnings calls
Key facts CIK 1135951 CUSIP 256135203 13F (30d) 49 filings 49 filers Visit website Investor relations